364 related articles for article (PubMed ID: 22364872)
1. New insights into the regulation of Na+,K+-ATPase by ouabain.
Silva E; Soares-da-Silva P
Int Rev Cell Mol Biol; 2012; 294():99-132. PubMed ID: 22364872
[TBL] [Abstract][Full Text] [Related]
2. Binding of ouabain and marinobufagenin leads to different structural changes in Na,K-ATPase and depends on the enzyme conformation.
Klimanova EA; Petrushanko IY; Mitkevich VA; Anashkina AA; Orlov SN; Makarov AA; Lopina OD
FEBS Lett; 2015 Sep; 589(19 Pt B):2668-74. PubMed ID: 26297827
[TBL] [Abstract][Full Text] [Related]
3. Interaction between cardiotonic steroids and Na,K-ATPase. Effects of pH and ouabain-induced changes in enzyme conformation.
Cornelius F; Mahmmoud YA
Biochemistry; 2009 Oct; 48(42):10056-65. PubMed ID: 19778013
[TBL] [Abstract][Full Text] [Related]
4. A role for the sodium, potassium adenosine triphosphatase (Na+,K+ ATPase) enzyme in degranulation of rat basophilic leukaemia cells.
Gentile DA; Skoner DP
Clin Exp Allergy; 1996 Dec; 26(12):1449-60. PubMed ID: 9027446
[TBL] [Abstract][Full Text] [Related]
5. Low-dose cardiotonic steroids increase sodium-potassium ATPase activity that protects hippocampal slice cultures from experimental ischemia.
Oselkin M; Tian D; Bergold PJ
Neurosci Lett; 2010 Apr; 473(2):67-71. PubMed ID: 19822191
[TBL] [Abstract][Full Text] [Related]
6. Cardiotonic steroid-resistant alpha1-Na+,K+-ATPase rescues renal epithelial cells from the cytotoxic action of ouabain: evidence for a Nai+,Ki+ -independent mechanism.
Akimova OA; Tremblay J; Van Huysse JW; Hamet P; Orlov SN
Apoptosis; 2010 Jan; 15(1):55-62. PubMed ID: 19949978
[TBL] [Abstract][Full Text] [Related]
7. Low-dose ouabain protects against excitotoxic apoptosis and up-regulates nuclear Bcl-2 in vivo.
Golden WC; Martin LJ
Neuroscience; 2006; 137(1):133-44. PubMed ID: 16297565
[TBL] [Abstract][Full Text] [Related]
8. Involvement of reactive oxygen species in a feed-forward mechanism of Na/K-ATPase-mediated signaling transduction.
Yan Y; Shapiro AP; Haller S; Katragadda V; Liu L; Tian J; Basrur V; Malhotra D; Xie ZJ; Abraham NG; Shapiro JI; Liu J
J Biol Chem; 2013 Nov; 288(47):34249-34258. PubMed ID: 24121502
[TBL] [Abstract][Full Text] [Related]
9. ATP1A1-mediated Src signaling inhibits coronavirus entry into host cells.
Burkard C; Verheije MH; Haagmans BL; van Kuppeveld FJ; Rottier PJ; Bosch BJ; de Haan CA
J Virol; 2015 Apr; 89(8):4434-48. PubMed ID: 25653449
[TBL] [Abstract][Full Text] [Related]
10. Ouabain interaction with cardiac Na/K-ATPase reveals that the enzyme can act as a pump and as a signal transducer.
Xie Z
Cell Mol Biol (Noisy-le-grand); 2001 Mar; 47(2):383-90. PubMed ID: 11357899
[TBL] [Abstract][Full Text] [Related]
11. Effects of cardiac glycosides on sodium pump expression and function in LLC-PK1 and MDCK cells.
Liu J; Periyasamy SM; Gunning W; Fedorova OV; Bagrov AY; Malhotra D; Xie Z; Shapiro JI
Kidney Int; 2002 Dec; 62(6):2118-25. PubMed ID: 12427136
[TBL] [Abstract][Full Text] [Related]
12. Na+/K+ATPase as a signaling molecule during bovine sperm capacitation.
Thundathil JC; Anzar M; Buhr MM
Biol Reprod; 2006 Sep; 75(3):308-17. PubMed ID: 16687652
[TBL] [Abstract][Full Text] [Related]
13. Natriuretic effect of bufalin in isolated rat kidneys involves activation of the Na+-K+-ATPase-Src kinase pathway.
Arnaud-Batista FJ; Costa GT; Oliveira IM; Costa PP; Santos CF; Fonteles MC; Uchôa DE; Silveira ER; Cardi BA; Carvalho KM; Amaral LS; Pôças ES; Quintas LE; Noël F; Nascimento NR
Am J Physiol Renal Physiol; 2012 Apr; 302(8):F959-66. PubMed ID: 22237798
[TBL] [Abstract][Full Text] [Related]
14. Sodium/potassium ATPase (Na+, K+-ATPase) and ouabain/related cardiac glycosides: A new paradigm for development of anti- breast cancer drugs?
Chen JQ; Contreras RG; Wang R; Fernandez SV; Shoshani L; Russo IH; Cereijido M; Russo J
Breast Cancer Res Treat; 2006 Mar; 96(1):1-15. PubMed ID: 16322895
[TBL] [Abstract][Full Text] [Related]
15. Na+/K+ pump and endothelial cell survival: [Na+]i/[K+]i-independent necrosis triggered by ouabain, and protection against apoptosis mediated by elevation of [Na+]i.
Orlov SN; Thorin-Trescases N; Pchejetski D; Taurin S; Farhat N; Tremblay J; Thorin E; Hamet P
Pflugers Arch; 2004 Jun; 448(3):335-45. PubMed ID: 15069561
[TBL] [Abstract][Full Text] [Related]
16. Intracerebroventricular administration of ouabain, a Na/K-ATPase inhibitor, activates mTOR signal pathways and protein translation in the rat frontal cortex.
Kim SH; Yu HS; Park HG; Ha K; Kim YS; Shin SY; Ahn YM
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():73-82. PubMed ID: 23643758
[TBL] [Abstract][Full Text] [Related]
17. 2-Methoxy-3,8,9-trihydroxy coumestan: a new synthetic inhibitor of Na+,K+-ATPase with an original mechanism of action.
Pôças ES; Costa PR; da Silva AJ; Noël F
Biochem Pharmacol; 2003 Dec; 66(11):2169-76. PubMed ID: 14609741
[TBL] [Abstract][Full Text] [Related]
18. [Na,K-ATPase and cardiac glycosides: new functions of the known protein].
Lopina OD
Ross Fiziol Zh Im I M Sechenova; 2005 Feb; 91(2):158-68. PubMed ID: 15835539
[TBL] [Abstract][Full Text] [Related]
19. ACTH-induced hypertension is dependent on the ouabain-binding site of the alpha2-Na+-K+-ATPase subunit.
Lorenz JN; Loreaux EL; Dostanic-Larson I; Lasko V; Schnetzer JR; Paul RJ; Lingrel JB
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H273-80. PubMed ID: 18487447
[TBL] [Abstract][Full Text] [Related]
20. Differential roles of caveolin-1 in ouabain-induced Na+/K+-ATPase cardiac signaling and contractility.
Bai Y; Wu J; Li D; Morgan EE; Liu J; Zhao X; Walsh A; Saikumar J; Tinkel J; Joe B; Gupta R; Liu L
Physiol Genomics; 2016 Oct; 48(10):739-748. PubMed ID: 27519543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
